» Articles » PMID: 35622077

Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.C

Abstract

Pre-exposure prophylaxis (PrEP) for HIV prevention is underutilized by cisgender women at risk for HIV in the USA. Published research on PrEP initiation among cisgender women at risk for HIV focuses on identifying barriers and facilitators associated with intention to initiate, but few apply a behavioral theoretical lens to understand the relative importance of these diverse factors. This study provides a theoretically grounded view of the relative importance of factors associated with intention to initiate PrEP. We conducted an anonymous, cross-sectional survey of 1437 cisgender women seeking care at family planning and sexual health clinics to evaluate hypothesized barriers and facilitators of PrEP initiation. We categorized cisgender women with ≥ 3 behavioral risk-factors as "high-risk" for HIV acquisition; 26.9% (N = 387) met high-risk criterion. Among cisgender women in the high-risk sample, the majority were Black and single. Perceived risk of HIV acquisition was low and 13.7% reported intention to initiate PrEP. Positive attitudes toward PrEP, self-efficacy, perceived support from medical providers and social networks, and prior discussion about PrEP with medical providers were associated with intention to initiate PrEP; stigma was negatively associated. Background characteristics (other than age), risk factors for HIV acquisition, prior awareness of PrEP, and perceived risk of HIV were not associated with uptake intention. These findings support interventions that center on the role of providers in the provision of PrEP and on social networks in destigmatization of PrEP use.

Citing Articles

HIV preexposure prophylaxis and postexposure prophylaxis in women: a comprehensive guide for healthcare providers.

Vora N, Badowski M Ther Adv Infect Dis. 2024; 11:20499361241300920.

PMID: 39650692 PMC: 11624534. DOI: 10.1177/20499361241300920.


Barriers to Oral PrEP: A Qualitative Study of Female Sex Workers, PrEP Prescribers, Policymakers, and Community Advocates in Morocco.

Ben Moussa A, Badahdah A, Hidous K, Barakad R, Diallo F, Traore M J Int Assoc Provid AIDS Care. 2024; 23:23259582241266691.

PMID: 39099547 PMC: 11299217. DOI: 10.1177/23259582241266691.


Predictors of PrEP Retention and Attrition in an Urban Publicly Funded Safety-net Specialty Clinic.

Drezner K, Coleman M, Visconti A, Thomas C, Beverley J, Harold R AIDS Behav. 2024; 28(8):2598-2606.

PMID: 38801502 PMC: 11325486. DOI: 10.1007/s10461-024-04378-z.


Age-related factors associated with intention to initiate pre-exposure prophylaxis among cisgender women in Washington D.C.

Zack J, Hull S, Coleman M, Ye P, Lotke P, Visconti A Ther Adv Infect Dis. 2024; 11:20499361241252351.

PMID: 38751758 PMC: 11095193. DOI: 10.1177/20499361241252351.


The Moderating Effects of HIV Relevant Factors on the Relationship Between Intimate Partner Violence and Intention to Start HIV Pre-exposure Prophylaxis (PrEP) Among Cisgender Women.

Keddem S, Frye V, Davis A, Koblin B, Tieu H, Lipsky R Arch Sex Behav. 2024; 53(4):1531-1539.

PMID: 38366311 DOI: 10.1007/s10508-024-02812-w.


References
1.
Goparaju L, Experton L, Praschan N, Warren-Jeanpiere L, Young M, Kassaye S . Women want Pre-Exposure Prophylaxis but are Advised Against it by Their HIV-positive Counterparts. J AIDS Clin Res. 2016; 6(11):1-10. PMC: 4807623. DOI: 10.4172/2155-6113.1000522. View

2.
Smith D, Van Handel M, Grey J . Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Ann Epidemiol. 2018; 28(12):850-857.e9. DOI: 10.1016/j.annepidem.2018.05.003. View

3.
Nydegger L, Dickson-Gomez J, Ko Ko T . A Longitudinal, Qualitative Exploration of Perceived HIV Risk, Healthcare Experiences, and Social Support as Facilitators and Barriers to PrEP Adoption Among Black Women. AIDS Behav. 2020; 25(2):582-591. PMC: 7855297. DOI: 10.1007/s10461-020-03015-9. View

4.
Murnane P, Celum C, Mugo N, Campbell J, Donnell D, Bukusi E . Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial. AIDS. 2014; 27(13):2155-60. PMC: 3882910. DOI: 10.1097/QAD.0b013e3283629037. View

5.
Koren D, Nichols J, Simoncini G . HIV Pre-Exposure Prophylaxis and Women: Survey of the Knowledge, Attitudes, and Beliefs in an Urban Obstetrics/Gynecology Clinic. AIDS Patient Care STDS. 2018; 32(12):490-494. DOI: 10.1089/apc.2018.0030. View